Chunlizhengda H shareholders reject key governance changes

Beijing Chunlizhengda Medical Instruments Co. announced that all three special resolutions, including the abolishment of the supervisory committee and amendments to the articles of association, as well as the rules of procedures for general and board meetings, failed to pass at its adjourned H shareholders' class meeting held on December 3, 2025. This means the proposed changes will not become effective, and the company will continue to operate under its existing governance framework.

The resolution to abolish the supervisory committee and amend the articles of association received 61.2067% "for" votes, but 38.7933% "against" votes, falling short of the required two-thirds majority for a special resolution. Similarly, proposed amendments to the rules of procedures for general meetings and board meetings each garnered 42.8945% "for" votes against 57.1055% "against" votes, also failing to pass.

A total of 21,965,737 H shares, representing 23.0877% of the total issued H shares, were represented at the meeting. The meeting was convened by the board and chaired by Ms. Shi Wenling, chairman of the board.